[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350425-105":59,"doc-detail-350425-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-metabolic-escape-how-tumor-metabolic-reprogramming-drives-drug-resistance","The metabolic escape - how tumor metabolic reprogramming drives drug resistance","","Metabolic reprogramming acts as a fundamental cancer hallmark and a key cause of drug resistance, enabling tumor cells to adapt and escape therapies. This review systematically examines aerobic glycolysis (Warburg effect), lactate metabolism, glutamine addiction, lipid synthesis reprogramming, and mitochondrial and ion metabolic changes. It explains how these rewired pathways mechanistically promote resistance and identifies molecular targets for intervention, while outlining emerging strategies to exploit metabolic vulnerabilities for precision oncology.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-metabolic-escape-how-tumor-metabolic-reprogramming-drives-drug-resistance/350425/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-metabolic-escape-how-tumor-metabolic-reprogramming-drives-drug-resistance/350425.png","ImageObject",300,407,{"name":92,"@type":93},"Dipper","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-09","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does metabolic reprogramming drive drug resistance in cancer?","Question",{"text":112,"@type":113},"Metabolic reprogramming rewires energy production, biomass synthesis, and redox homeostasis, allowing tumor cells to adapt to stress and evade therapy, which undermines treatment efficacy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which metabolic pathways are highlighted as contributors to resistance?",{"text":117,"@type":113},"The review focuses on aerobic glycolysis (Warburg effect), lactate metabolism, glutamine addiction, lipid synthesis reprogramming, and changes in mitochondrial and ion homeostasis.",{"name":119,"@type":110,"acceptedAnswer":120},"How do metabolic heterogeneity and the tumor microenvironment affect resistance?",{"text":121,"@type":113},"Metabolic heterogeneity and the tumor microenvironment contribute to resistance, including distinct metabolic programs in cancer stem cells and protective metabolite secretion from stromal cells.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350425,1790182020,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374404997633,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Submitted 11 December 2025 Accepted 27 April 2026  \nPublished 8 June 2026  \nCorresponding authors Wenzhe Si, [wenzhesi@bjmu.edu.cn](wenzhesi@bjmu.edu.cn)[ ](wenzhesi@bjmu.edu.cn)Xujun Liu, [xujunliu@bjmu.edu.cn](xujunliu@bjmu.edu.cn)  \nAcademic editor Vladimir Uversky  \nAdditional Information and Declarations can be found on page 28  \nDOI 10.7717/peerj.21400  \n Copyright 2026 Chen et al.  \nDistributed under  \nCreative Commons CC-BY 4.0  \nOPEN ACCESS  \nThe metabolic escape: how tumor metabolic reprogramming drives drug resistance  \nYan Chen1 , Zixu Wu1 , Wenzhe Si2 and Xujun Liu1  \n1 Department of Laboratory Medicine, Peking University First Hospital, Beijing, China  \n2 Department of Laboratory Medicine, State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University Third Hospital, Beijing, China  \nABSTRACT  \nIn the last few years, metabolic reprogramming has been recognized as a fundamental characteristic of cancer, and is also acknowledged as a crucial cause to drug resistance, which consistently acts as a significant barrier in cancer treatment by allowing tumor cells to adapt and escape various therapies. This review gives a systematically investigation of how metabolic reprogramming contributes to drug resistance in cancer, including aerobic glycolysis (also known as the Warburg effect), lactate metabolism, glutamine addiction, lipid synthesis reprogramming, mitochondrial and ion metabolic changes. Furthermore, by clarifying the mechanisms behind these reprogrammed metabolic pathways, we explain how these changes lead to drug resistance and highlight potential molecular targets for therapeutic intervention. Additionally, we discuss emerging strategies aimed at exploiting these metabolic vulnerabilities, offering new insights for overcoming drug resistance in cancer. By integrating recent discoveries in this field, we present a unified perspective on targeting metabolic vulnerabilities to overcome drug resistance, which is an urgent need in precision oncology, and timely and concise insights for cancer biologists and researchers in the field of exploring the metabolic mechanisms of drug resistance. We hope this review will provide valuable insights for molecular tumor biologists seeking to elucidate the molecular roles of tumor metabolic reprogramming and drug resistance in cancer.  \nSubjects Cell Biology, Molecular Biology  \nKeywords Cancer, Metabolic reprogramming, Drug resistance, Tumor microenvironment, Cancer therapeutics  \nRATIONALE  \nCancer remains a leading cause of mortality worldwide, with drug resistance representing a major therapeutic obstacle. Metabolic reprogramming has emerged as a fundamental hallmark of cancer and a pivotal driver of this resistance.  \nThis rewiring of cellular metabolism allows cancer cells to sustain proliferation, adapt to stress, and evade therapy. Furthermore, metabolic heterogeneity and the tumor microenvironment (TME) critically contribute to resistance; cancer stem cells utilize distinct metabolic pathways, and stromal cells secrete metabolites that protect tumors. We systematically explores how core reprogrammed pathways, including aerobic glycolysis, lactate metabolism, glutamine addiction, lipid synthesis, and alterations in mitochondrial  \nHow to cite this article Chen Y, Wu Z, Si W, Liu X. 2026. The metabolic escape: how tumor metabolic reprogramming drives drug resis  \ntance. PeerJ 14:e21400 [http://doi.org/10.7717/peerj.21400](http://doi.org/10.7717/peerj.21400)  \nand ion homeostasis. By integrating recent advances, we aim to highlight the mechanisms underpinning this metabolic escape and discuss emerging therapeutic strategies designed to target these vulnerabilities, offering new avenues to overcome resistance in cancer treatment.  \nINTRODUCTION  \nCancer remains a leading global health burden, with close to 20 million new cases and 9.7 million deaths reported worldwide in 2022 alone (Bray et al., 2024) . Despite advancements in early detection and therapeut","cbCail7NK4zzMSMF","https://ap.wps.com/l/cbCail7NK4zzMSMF","pdf",5101191,35,"English","# Abstract\n# Rationale\n# Introduction","[{\"question\":\"How does metabolic reprogramming drive drug resistance in cancer?\",\"answer\":\"Metabolic reprogramming rewires energy production, biomass synthesis, and redox homeostasis, allowing tumor cells to adapt to stress and evade therapy, which undermines treatment efficacy.\"},{\"question\":\"Which metabolic pathways are highlighted as contributors to resistance?\",\"answer\":\"The review focuses on aerobic glycolysis (Warburg effect), lactate metabolism, glutamine addiction, lipid synthesis reprogramming, and changes in mitochondrial and ion homeostasis.\"},{\"question\":\"How do metabolic heterogeneity and the tumor microenvironment affect resistance?\",\"answer\":\"Metabolic heterogeneity and the tumor microenvironment contribute to resistance, including distinct metabolic programs in cancer stem cells and protective metabolite secretion from stromal cells.\"}]","The metabolic escape - how tumor metabolic reprogramming drives drug resistance | PDF",1790088953,88,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/efa00238246b8cb3d31c8e2a85640c37.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9de40c32f0c033517eb8d64a1606bc35.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2566d926a8d8a42e484c15dc66bdc761.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cef8a2a41d11e6e9de30d4f6c1e9b840.webp",980,1268]